Efficacy and Safety of Mate Extracts on Decrement of Body and Abdominal Fat in Obese Subjects

Chonbuk National University

Status and phase

Completed

Phase 2

Conditions

Obesity

Treatments

Dietary Supplement: Placebo

Dietary Supplement: Mate extract

Study type

Interventional

Funder types

Other

Identifiers

NCT01778257

CUH_2011_GS_MATE

Details and patient eligibility

About

Obesity is a major health issue worldwide; there is a constant raise in obesity related death each year.

Full description

The primary aim of the study was to investigate the effect of Mate extracts in Korean subjects on body fat and abdominal fat, double blind, placebo-controlled clinical trial.

Thirty obesity subjects with BMI ≥ 25 kg/㎡ and waist-hip ratio (WHR)≥ 0.90 for men and ≥ 0.85 for women were for 12 weeks.

Enrollment

30 patients

Sex

All

Ages

19 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Volunteers aged 19 to 65 years
25 kg/m2 ≤ BMI ≥35 kg/m2
Ability to give informed consent

Exclusion criteria

Significant variation in weight (more 10%) in the past 3 month
Cardiovascular disease, neurologic or psychiatric disease, renal, pulmonary and hepatic abnormalities
History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease (Crohn's disease) or gastrointestinal surgery (a caesum or enterocele surgery are included)
Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the sutdy
Allergic or hypersensitive to any of the ingredients in the test products
Pregnancy or breast feeding
Used antipsychosis drugs therapy within past 2 months
History of alcohol or substance abuse (21 units/week over)
Participation in any other clinical trials within past 3 months